News UK will start first COVID-19 challenge study “within a month” Sometime within the next few weeks, young and healthy volunteers will … 18 February, 2021
News GSK expands coronavirus antibody tie-up to include potential flu therapies GlaxoSmithKline is expanding a coronavirus antibody collaboration … 18 February, 2021
News South African variant may cut response from Pfizer/BioNTech shot, study finds The South African coronavirus variant may cut the effectiveness of … 18 February, 2021
Views & Analysis No cooling off for pharma digital transformation in 2021 COVID-19 has already proved to be a digital accelerant for the … 18 February, 2021
Others Medical meetings post-COVID – key lessons for pharma EPG Health’s Allen Wellings assesses future symposia and congress … 21 July, 2021
Views & Analysis West Africa prepares for Ebola vaccination program Amidst the COVID-19 pandemic, West Africa is facing a new outbreak of … 22 September, 2021
Others Digital transformation in pharma TEST Using AI to make a big impact for emerging and mid-sized biopharma … 22 September, 2021
Others Test 5 best practices for improving patient engagement Life science companies invest a significant number of resources to … 17 March, 2022
Others Preparing industry leaders for digital transformation Digital transformation is taking root in every major industry, and … 17 March, 2022
Partner Content Partner Content Three strategies for managing loss of exclusivity successfully “Patent losses could sink Allergan”. 1 “Drug prices to plummet in … 18 February, 2021
Partner Content Partner Content Building early relationships: a gamechanger for pioneering rare disease treatment Advocacy groups play a crucial role in both driving access to … 17 February, 2021
News Filing beckons as Lynparza hits the mark in adjuvant breast cancer AstraZeneca’s PARP inhibitor Lynparza has shown a clinical benefit … 17 February, 2021